drugset / Trial / NCT00627016

A Study of Dexlansoprazole Modified Release Formulation to Treat Night Heartburn

NCT00627016

Phase 3 Completed 305 enrolled Takeda
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine whether Dexlansoprazole once daily (QD) is effective in treating patients with night heartburn.

Timeline

Start
2008-03
Primary completion
2009-03
Completion
2009-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexlansoprazole Other / unclassified 30 mg Oral